Sector revisions Genscript Biotech Corporation

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:36 10/07/2026 BST			5-day change	1st Jan Change
13.84 ^HKD	+4.85%		+1.69%	+11.43%

06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT
06-14	Genscript Biotech Corporation Reports 100% Response Rate in Early Trial of LB2501 Dual-Targeting CAR-T Therapy for Relapsed B-Cell Lymphoma	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
GENSCRIPT BIOTECH CORPORATION		7
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		22
IQVIA HOLDINGS INC.		19
BEONE MEDICINES AG		27
CELLTRION, INC.		24
ASCENDIS PHARMA A/S	-	18
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
ICON PUBLIC LIMITED COMPANY		16
ABIVAX		6
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
BIO-TECHNE CORPORATION		12
TEMPUS AI, INC.		16
IONIS PHARMACEUTICALS, INC.		22
APOGEE THERAPEUTICS, INC.		12
KYMERA THERAPEUTICS, INC.		21
PRAXIS PRECISION MEDICINES, INC.		18
ALKERMES PLC		16
PROTAGONIST THERAPEUTICS, INC.		13
Average		17
Weighted average by Cap.		19